T. Komori

Polyol pathway hyperactivity is closely related to carnitine deficiency in the pathogenesis of diabetic neuropathy of streptozotocin-diabetic rats.

N. Hotta, E. Nakashima, K. Naruse, 1998, The Journal of pharmacology and experimental therapeutics.

Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides.

N. Hotta, K. Naruse, Y. Hamada, 1997, Canadian journal of physiology and pharmacology.

Biguanides may produce hypoglycemic action in isolated rat hepatocytes through their effects on L-alanine transport.

N. Hotta, N. Koh, N. Sakamoto, 1993, Diabetes research and clinical practice.

The inhibitory action of buformin, a biguanide on gluconeogenesis from alanine and its transport system in rat livers.

N. Hotta, N. Koh, N. Sakamoto, 1993, Diabetes research and clinical practice.

Dependence of cholecystokinin-8-stimulated insulin release on high glucose levels is evidenced by pseudo-alpha-D-glucose in rat pancreas and islets.

I. Kimura, M. Kimura, T. Komori, 1994, Japanese journal of pharmacology.

Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes.

N. Hotta, K. Naruse, Y. Hamada, 2000, Experimental eye research.

The effect of 1α-hydroxyvitamin D3 on primary antibody formation in mice

Y. Ohsugi, T. Nakano, T. Komori, 1985 .

Norspermidine inhibits LPS-induced immunoglobulin production in an FCS-independent mechanism different from spermidine and spermine.

Y. Ohsugi, T. Komori, 1991, International journal of immunopharmacology.

An aldose redutase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs

N. Hotta, K. Naruse, Y. Hamada, 1999, Diabetologia.

Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effects on eating behavior and serum leptin levels.

A. Iguchi, J. Nakamura, S. Miyazaki, 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Epalrestat , an Aldose Reductase Inhibitor , Reduces the Levels of N ε-( Carboxymethyl ) lysine Protein Adducts and Their Precursors in Erythrocytes From Diabetic Patients

N. Hotta, S. Horiuchi, K. Naruse, 2000 .

An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells.

N. Hotta, G. Watanabe, K. Naruse, 1999, Biochemical and biophysical research communications.

Alleviation of depressed immunity caused by restraint-stress, by the immunomodulator, lobenzarit disodium (disodium 4-chloro-2,2'-iminodibenzoate).

Y. Ohsugi, T. Nakano, T. Komori, 1987, International journal of immunopharmacology.